Alvotech (ALVO) Cash from Operations (2021 - 2026)
Alvotech's (ALVO) quarterly Cash from Operations came in at 25246000.0 in Q1 2026, down 245.22% YoY from 17385000.0 in Q1 2025, and down 117.12% on a QoQ basis from 147444000.0 in Q4 2025.
Alvotech (ALVO) Cash from Operations (2021 - 2026) Analysis & Trends
Alvotech (ALVO) has 6 years of Cash from Operations data on file, last reported at 25246000.0 in Q1 2026.
- Quarterly Cash from Operations fell 245.22% year-over-year to 25246000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 92828000.0 (up 72.83% YoY) and the FY2025 annual result came in at 50197000.0, up 78.81% from the prior year.
- Cash from Operations retreated to 25246000.0 in Q1 2026, from 147444000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 147444000.0 in Q4 2025 to a low of 312389000.0 in Q4 2022.
- A 5-year average of 93577266.67 and a median of 71641000.0 in 2024 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2022 — Cash from Operations tumbled 341.49% — and 2025, when it jumped 200.61%.
- Tracing ALVO's Cash from Operations over 5 years: stood at 312389000.0 in 2022, then gained by 0.07% to 312185000.0 in 2023, then gained by 24.13% to 236843000.0 in 2024, then surged by 162.25% to 147444000.0 in 2025, then plunged by 117.12% to 25246000.0 in 2026.
- The last three Cash from Operations figures came in at 25246000.0 (Q1 2026), 147444000.0 (Q4 2025), and 265932000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Alvotech | 1.30 Bn | 1.30 Bn | 5.09 Mn | -60.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25.25 Mn |
| Mar 31, 2026 | -25.25 Mn |
| Dec 31, 2025 | 147.44 Mn |
| Dec 31, 2025 | 147.44 Mn |
| Sep 30, 2025 | -265.93 Mn |
| Sep 30, 2025 | -265.93 Mn |
| Jun 30, 2025 | 50.91 Mn |
| Jun 30, 2025 | 50.91 Mn |
| Mar 31, 2025 | 17.39 Mn |
| Mar 31, 2025 | 17.39 Mn |
| Dec 31, 2024 | -236.84 Mn |
| Dec 31, 2024 | -236.84 Mn |
| Sep 30, 2024 | -71.64 Mn |
| Sep 30, 2024 | -71.64 Mn |
| Jun 30, 2024 | -50.60 Mn |
| Jun 30, 2024 | -50.60 Mn |
| Mar 31, 2024 | -75.40 Mn |
| Mar 31, 2024 | -75.40 Mn |
| Dec 31, 2023 | -312.19 Mn |
| Dec 31, 2023 | -312.19 Mn |